Equillium (EQ) Non Operating Income (2018 - 2024)
Equillium's (EQ) quarterly Non Operating Income came in at $57000.0 in Q1 2024, down 75.0% year-on-year from $228000.0 in Q2 2023, and down 75.0% on a QoQ basis from $228000.0 in Q1 2023.
Equillium (EQ) Non Operating Income (2018 - 2024) Analysis & Trends
Equillium (EQ) has 7 years of Non Operating Income data on file, last reported at $57000.0 in Q1 2024.
- On a quarterly basis, Non Operating Income fell 75.0% year-over-year to $57000.0 in Q1 2024; TTM through Mar 2024 was $598000.0, a 1761.11% increase from a year earlier, with the FY2023 full-year figure at $1.8 million, up 601.99% from the prior year.
- Non Operating Income for Q1 2024 stood at $57000.0, down from $228000.0 in the prior quarter.
- Over the last five years, Non Operating Income for EQ reached as high as $731000.0 in Q4 2022 and fell as low as -$577000.0 in Q2 2022.
- Historically, Non Operating Income has averaged -$114142.9 across 5 years, with a median of -$161000.0 in 2021.
- Across the five-year window, Non Operating Income sank 550.0% in 2021 and surged 412.39% in 2022, its largest moves.
- Year by year, Non Operating Income stood at $52000.0 in 2020, then sank by 550.0% to -$234000.0 in 2021, then jumped by 412.39% to $731000.0 in 2022, then plunged by 68.81% to $228000.0 in 2023, then slumped by 75.0% to $57000.0 in 2024.
- Per Business Quant data, the three most recent Non Operating Income figures were $57000.0 in Q1 2024, $228000.0 in Q1 2023, and $731000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 57,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | 731,000.00 |
| Sep 30, 2022 | -418,000.00 |
| Jun 30, 2022 | -577,000.00 |
| Mar 31, 2022 | -88,000.00 |
| Dec 31, 2021 | -234,000.00 |
| Sep 30, 2021 | -421,000.00 |
| Jun 30, 2021 | -315,000.00 |
| Mar 31, 2021 | -296,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Sep 30, 2020 | -81,000.00 |
| Jun 30, 2020 | 149,000.00 |
| Mar 31, 2020 | -385,000.00 |
| Dec 31, 2019 | 49,000.00 |
| Sep 30, 2019 | 310,000.00 |
| Jun 30, 2019 | 370,000.00 |
| Mar 31, 2019 | 398,000.00 |
| Dec 31, 2018 | -764,000.00 |
| Sep 30, 2018 | -2.69 Mn |